The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2017

Filed:

May. 30, 2014
Applicant:

National University Corporation Chiba University, Chiba, JP;

Inventors:

Toshinori Nakayama, Chiba, JP;

Hiroyuki Hosokawa, Chiba, JP;

Koji Tokoyoda, Chiba, JP;

Koji Hayashizaki, Chiba, JP;

Akane Suzuki, Chiba, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); G01N 33/68 (2006.01); G01N 33/566 (2006.01); C07K 14/47 (2006.01); A61K 39/395 (2006.01); A61P 11/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); G01N 33/566 (2013.01); G01N 33/6887 (2013.01); A61K 39/395 (2013.01); A61K 2039/505 (2013.01); C07K 14/4716 (2013.01); C07K 2317/34 (2013.01); G01N 2333/4712 (2013.01); G01N 2333/70596 (2013.01); G01N 2500/02 (2013.01);
Abstract

Provided is a means for inhibiting a function of CD69, whereby allowing suppression of an inflammatory response. That is, provided are: a composition for treating an inflammatory disease which includes an antibody that specifically recognizes a myosin regulatory light chain polypeptide (hereinafter abbreviated as Myl), preferably Myl9, Myl12a, and Myl12b, and inhibits a result of an effect of coexistence of Myl with CD69; a method of treating an inflammatory disease, including administering, to a subject diagnosed as having an inflammatory disease, a therapeutically effective amount of the antibody; and a method of identifying a compound that inhibits a result of an effect of coexistence of Myl with CD69, and a method of identifying a candidate compound for treating an inflammatory disease, including selecting a compound that inhibits the result.


Find Patent Forward Citations

Loading…